Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page
- CheckyesterdayChange DetectedAdded a funding/status notice and a version revision (v3.4.1). Removed Melanoma and related topics (MedlinePlus Genetics) from the page.SummaryDifference0.6%

- Check8 days agoChange DetectedThe page now displays a glossary option and adds new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). It also removes the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded Melanoma as a topic label, added related topic 'MedlinePlus Genetics', and updated page revision from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check29 days agoChange DetectedRemoved the Melanoma topic and the MedlinePlus Genetics related topic from the Study Details page.SummaryDifference0.2%

- Check43 days agoChange DetectedLocations section updated to include Kentucky, Pennsylvania, and Texas, with the page revision updated to v3.3.3.SummaryDifference0.5%

- Check64 days agoChange DetectedAdded Melanoma and MedlinePlus Genetics as related topics on the study page. These additions serve as metadata for context and indexing.SummaryDifference0.2%

Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.